Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schwarzer

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Viral Hepatitis|August 7, 2009
Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis CG Sroczynski, E Esteban, A Conrads-Frank, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2018
Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response studyR Schwarzer, D Kivaranovic, R Paternostro, et al.
Leukemia|June 6, 2008
Notch inhibition blocks multiple myeloma cell-induced osteoclast activationR Schwarzer, M Kaiser, O Acikgoez, et al.
Zeitschrift Fur Experimentelle Chirurgie|January 1, 1973
[Results of orthotopic homologous liver transplantation]R Schwarzer, H Wolff, E Woschick, et al.
Leukemia|May 2, 2008
Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphomaF Jundt, O Acikgöz, S-H Kwon, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertensionR Schwarzer, D Kivaranovic, M Mandorfer, et al.
Communications Medicine|November 20, 2024
Inferring the regional distribution of Visceral Leishmaniasis incidence from data at different spatial scalesEmily S Nightingale, Swaminathan Subramanian, Ashley R Schwarzer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Viral Hepatitis|August 7, 2009
Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis CG Sroczynski, E Esteban, A Conrads-Frank, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2018
Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response studyR Schwarzer, D Kivaranovic, R Paternostro, et al.
Leukemia|June 6, 2008
Notch inhibition blocks multiple myeloma cell-induced osteoclast activationR Schwarzer, M Kaiser, O Acikgoez, et al.
Zeitschrift Fur Experimentelle Chirurgie|January 1, 1973
[Results of orthotopic homologous liver transplantation]R Schwarzer, H Wolff, E Woschick, et al.
Leukemia|May 2, 2008
Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphomaF Jundt, O Acikgöz, S-H Kwon, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertensionR Schwarzer, D Kivaranovic, M Mandorfer, et al.
Communications Medicine|November 20, 2024
Inferring the regional distribution of Visceral Leishmaniasis incidence from data at different spatial scalesEmily S Nightingale, Swaminathan Subramanian, Ashley R Schwarzer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Pageof 4